Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Cytosorbents Corp | ctso-20210331xex31d1.htm |
| EX-32.2 - EXHIBIT 32.2 - Cytosorbents Corp | ctso-20210331xex32d2.htm |
| EX-31.2 - EXHIBIT 31.2 - Cytosorbents Corp | ctso-20210331xex31d2.htm |
| 10-Q - 10-Q - Cytosorbents Corp | ctso-20210331x10q.htm |
Exhibit 32.1
CERTIFICATION OF
PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Phillip Chan, Chief Executive Officer of CytoSorbents Corporation, hereby certify, that, to my knowledge:
1. | The Quarterly Report on Form 10-Q for the quarter ending March 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in such Quarterly Report on Form 10-Q for the quarter ending March 31, 2021, fairly presents, in all material respects, the financial condition and results of operations of CytoSorbents Corporation. |
Date: | May 4, 2021 | |
| | |
CYTOSORBENTS CORPORATION | | |
| | |
By: | /s/ Phillip P. Chan | |
| | |
| | |
Phillip Chan Chief Executive Officer | | |